Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P MALEK

Showing results (91-100 of 185) with videos related to

Pageof 19
Sort By:
Diagnostics (Basel, Switzerland)|April 13, 2024
Incidence of Secondary Sclerosing Cholangitis in Hospitalized Long COVID-19 Patients: A Retrospective Single Center StudyChristoph R Werner, Stefano Fusco, Katharina Kienzle, et al.
Virology Journal|April 19, 2015
First-generation protease inhibitor-triple therapy: SVR 24, safety, and predictors of response in a large single center cohortChristoph R Werner, Carolin Franz, Daniel P Egetemeyr, et al.
Plos One|November 23, 2013
Feasibility of telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: SVR 24 resultsChristoph R Werner, Daniel P Egetemeyr, Ulrich M Lauer, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 4, 2012
Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy dataChristoph R Werner, Daniel P Egetemeyr, Ulrich M Lauer, et al.
Carcinogenesis|December 3, 2013
Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progressionVindhya Palagani, Przemyslaw Bozko, Mona El Khatib, et al.
Gastroenterology Research and Practice|July 22, 2011
Combination of conservative and interventional therapy strategies for intra- and extrahepatic cholangiocellular carcinoma: a retrospective survival analysisM Knüppel, S Kubicka, A Vogel, et al.
The EMBO Journal|October 21, 2006
C-terminal phosphorylation controls the stability and function of p27kip1Uta Kossatz, Jörg Vervoorts, Irina Nickeleit, et al.
Zeitschrift Fur Gastroenterologie|January 15, 2014
Treatment of recurrent genotype 1 hepatitis C post-liver transplantation: single center experience with telaprevir-based triple therapyC R Werner, D P Egetemeyr, S Nadalin, et al.
Inflammatory Intestinal Diseases|March 2, 2019
Human Endogenous Retroviruses: Residues of Ancient Times Are Differentially Expressed in Crohn's DiseaseThomas Klag, Lioba Courth, Maureen J Ostaff, et al.
Diagnostics (Basel, Switzerland)|January 22, 2024
Analysis of Predictors and Risk Factors of Postpolypectomy SyndromeStefano Fusco, Michelle E Bauer, Ulrike Schempf, et al.
Pageof 19

Showing results (91-100 of 185) with videos related to

Sort By:
Pageof 19
Diagnostics (Basel, Switzerland)|April 13, 2024
Incidence of Secondary Sclerosing Cholangitis in Hospitalized Long COVID-19 Patients: A Retrospective Single Center StudyChristoph R Werner, Stefano Fusco, Katharina Kienzle, et al.
Virology Journal|April 19, 2015
First-generation protease inhibitor-triple therapy: SVR 24, safety, and predictors of response in a large single center cohortChristoph R Werner, Carolin Franz, Daniel P Egetemeyr, et al.
Plos One|November 23, 2013
Feasibility of telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: SVR 24 resultsChristoph R Werner, Daniel P Egetemeyr, Ulrich M Lauer, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 4, 2012
Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy dataChristoph R Werner, Daniel P Egetemeyr, Ulrich M Lauer, et al.
Carcinogenesis|December 3, 2013
Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progressionVindhya Palagani, Przemyslaw Bozko, Mona El Khatib, et al.
Gastroenterology Research and Practice|July 22, 2011
Combination of conservative and interventional therapy strategies for intra- and extrahepatic cholangiocellular carcinoma: a retrospective survival analysisM Knüppel, S Kubicka, A Vogel, et al.
The EMBO Journal|October 21, 2006
C-terminal phosphorylation controls the stability and function of p27kip1Uta Kossatz, Jörg Vervoorts, Irina Nickeleit, et al.
Zeitschrift Fur Gastroenterologie|January 15, 2014
Treatment of recurrent genotype 1 hepatitis C post-liver transplantation: single center experience with telaprevir-based triple therapyC R Werner, D P Egetemeyr, S Nadalin, et al.
Inflammatory Intestinal Diseases|March 2, 2019
Human Endogenous Retroviruses: Residues of Ancient Times Are Differentially Expressed in Crohn's DiseaseThomas Klag, Lioba Courth, Maureen J Ostaff, et al.
Diagnostics (Basel, Switzerland)|January 22, 2024
Analysis of Predictors and Risk Factors of Postpolypectomy SyndromeStefano Fusco, Michelle E Bauer, Ulrike Schempf, et al.
Pageof 19